Stocks
Sabra Health Care Financial Statements (SBRA) |
||||||||||
| Sabra Health Caresmart-lab.ru | % | 2021 | 2022 | 2022 | 2022 | 2023 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 30.03.2022 | 31.12.2022 | 21.02.2023 | 20.03.2023 | 27.02.2024 | 31.10.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 569.5 | 624.8 | 624.8 | 624.8 | 655.8 | 609.7 | |||
| Operating Income, bln rub | 19.0 | 234.7 | 135.6 | 135.6 | 218.6 | 200.2 | ||||
| EBITDA, bln rub | ? | 198.0 | 216.9 | 323.4 | 323.4 | 418.2 | 431.7 | |||
| Net profit, bln rub | ? | -113.3 | -77.6 | -77.6 | -77.6 | 13.8 | 97.2 | |||
| OCF, bln rub | ? | 356.4 | 315.7 | 315.7 | 315.7 | 300.6 | 309.3 | |||
| CAPEX, bln rub | ? | 33.6 | 0.000 | 0.000 | 0.000 | 0.000 | 5.27 | |||
| FCF, bln rub | ? | 322.8 | 315.7 | 315.7 | 315.7 | 300.6 | 314.6 | |||
| Dividend payout, bln rub | 262.9 | 277.2 | 277.2 | 277.2 | 277.4 | 278.5 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 0.00% | 0.00% | 0.00% | 0.00% | 2 017% | 286.6% | ||||
| OPEX, bln rub | 217.6 | 227.5 | 227.5 | 227.5 | 42.4 | 83.0 | ||||
| Cost of production, bln rub | 141.2 | 162.6 | 162.6 | 162.6 | 378.3 | 334.6 | ||||
| R&D, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| Interest expenses, bln rub | 98.6 | 105.5 | 105.5 | 105.5 | 113.0 | 130.7 | ||||
| Assets, bln rub | 5 967 | 5 748 | 5 748 | 5 748 | 5 386 | 5 366 | ||||
| Net Assets, bln rub | ? | 3 380 | 3 056 | 3 056 | 3 056 | 2 803 | 2 745 | |||
| Debt, bln rub | 2 394 | 2 507 | 2 704 | 2 704 | 2 447 | 2 498 | ||||
| Cash, bln rub | 112.0 | 49.3 | 49.3 | 49.3 | 46.7 | 63.0 | ||||
| Net debt, bln rub | 2 282 | 2 457 | 2 654 | 2 654 | 2 400 | 2 435 | ||||
| Ordinary share price, rub | 13.5 | 12.4 | 12.4 | 12.4 | 14.3 | 14.2 | ||||
| Number of ordinary shares, mln | 219.1 | 230.9 | 230.9 | 230.9 | 231.2 | 234.3 | ||||
| Market cap, bln rub | 2 966 | 2 871 | 2 871 | 2 871 | 3 299 | 3 334 | ||||
| EV, bln rub | ? | 5 249 | 5 328 | 5 525 | 5 525 | 5 699 | 5 769 | |||
| Book value, bln rub | 3 325 | 3 016 | 3 016 | 3 016 | 2 772 | 2 716 | ||||
| EPS, rub | ? | -0.52 | -0.34 | -0.34 | -0.34 | 0.06 | 0.41 | |||
| FCF/share, rub | 1.47 | 1.37 | 1.37 | 1.37 | 1.30 | 1.34 | ||||
| BV/share, rub | 15.2 | 13.1 | 13.1 | 13.1 | 12.0 | 11.6 | ||||
| EBITDA margin, % | ? | 34.8% | 34.7% | 51.8% | 51.8% | 63.8% | 70.8% | |||
| Net margin, % | ? | -19.9% | -12.4% | -12.4% | -12.4% | 2.10% | 15.9% | |||
| FCF yield, % | ? | 10.9% | 11.0% | 11.0% | 11.0% | 9.11% | 9.44% | |||
| ROE, % | ? | -3.35% | -2.54% | -2.54% | -2.54% | 0.49% | 3.54% | |||
| ROA, % | ? | -1.90% | -1.35% | -1.35% | -1.35% | 0.26% | 1.81% | |||
| P/E | ? | -26.2 | -37.0 | -37.0 | -37.0 | 239.8 | 34.3 | |||
| P/FCF | 9.19 | 9.09 | 9.09 | 9.09 | 11.0 | 10.6 | ||||
| P/S | ? | 5.21 | 4.59 | 4.59 | 4.59 | 5.03 | 5.47 | |||
| P/BV | ? | 0.89 | 0.95 | 0.95 | 0.95 | 1.19 | 1.23 | |||
| EV/EBITDA | ? | 26.5 | 24.6 | 17.1 | 17.1 | 13.6 | 13.4 | |||
| Debt/EBITDA | 11.5 | 11.3 | 8.21 | 8.21 | 5.74 | 5.64 | ||||
| R&D/CAPEX, % | 0.00% | 0 | ||||||||
| CAPEX/Revenue, % | 5.90% | 0.00% | 0.00% | 0.00% | 0.00% | 0.86% | ||||
| Sabra Health Care shareholders | ||||||||||
